Results
1861
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
1861 companies
Wuhan Hiteck Biological PharmaLtd
Market Cap: CN¥3.1b
A biopharmaceutical company, engages in the research and development, production, and sale of bio engineering products and freeze-dried powder injection in China.
300683
CN¥24.02
7D
2.0%
1Y
-0.2%
Beijing Sun-Novo Pharmaceutical Research
Market Cap: CN¥4.9b
A contract research company, engages in the research and development of drugs in China.
688621
CN¥44.95
7D
4.5%
1Y
-11.3%
Guangdong VTR Bio-Tech
Market Cap: CN¥3.7b
Researches, develops, produces, sells, and services biological enzyme preparations, biosynthetics, and nutrition and health products in China.
300381
CN¥7.71
7D
-1.7%
1Y
7.8%
Suzhou Zelgen BiopharmaceuticalsLtd
Market Cap: CN¥26.2b
Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
688266
CN¥99.00
7D
7.4%
1Y
80.8%
Gujarat Terce Laboratories
Market Cap: ₹429.7m
Develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally.
524314
₹57.91
7D
-1.2%
1Y
5.6%
Bilcare
Market Cap: ₹1.8b
Provides pharmaceutical packaging research solutions in India and internationally.
526853
₹76.72
7D
2.4%
1Y
18.2%
Theragen EtexLtd
Market Cap: ₩110.6b
Engages in the research and development, production, and sale of pharmaceutical products in Korea.
A066700
₩3,015.00
7D
-0.2%
1Y
-22.8%
Biocure Technology
Market Cap: CA$522.2k
Together with its subsidiary, engages in developing and commercializing biopharmaceutical technologies for use in recombinant and ranibizumab.
CURE.X
CA$0.05
7D
0%
1Y
n/a
Beijing Biostar Pharmaceuticals
Market Cap: HK$1.6b
A synthetic biology-driven biopharmaceutical company, engages in the research and development, production, and commercialization of oncology products in the People’s Republic of China.
2563
HK$4.41
7D
0%
1Y
n/a
Welgene BiotechLtd
Market Cap: NT$494.1m
Provides genetic testing services.
6661
NT$21.20
7D
-0.7%
1Y
-4.9%
Walvax Biotechnology
Market Cap: CN¥16.3b
Researches, develops, produces, and markets vaccines in China.
300142
CN¥10.17
7D
-0.7%
1Y
-27.3%
Cutia Therapeutics
Market Cap: HK$2.6b
An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.
2487
HK$8.30
7D
35.4%
1Y
14.0%
Guiyang Xintian PharmaceuticalLtd
Market Cap: CN¥2.1b
Engages in the research and development, production, and sale of new Chinese patent medicines in China.
002873
CN¥9.07
7D
1.3%
1Y
-11.3%
BF Biosciences
Market Cap: PK₨16.3b
A diversified biotech pharmaceutical company, manufactures, imports, and sells pharmaceutical products.
BFBIO
PK₨184.90
7D
21.0%
1Y
n/a
Rekah Pharmaceutical Industry
Market Cap: ₪157.2m
Engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel.
REKA
₪13.77
7D
10.2%
1Y
6.1%
Shanxi Zhendong PharmaceuticalLtd
Market Cap: CN¥4.2b
Engages in the research and development, production, and sales of pharmaceutical drugs in China and internationally.
300158
CN¥4.23
7D
8.2%
1Y
-6.6%
Shilpa Medicare
Market Cap: ₹63.8b
Manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, recombinant albumin in India, the United States, Europe, and internationally.
530549
₹735.00
7D
2.8%
1Y
45.7%
Jilin Aodong Pharmaceutical Group
Market Cap: CN¥19.2b
Jilin Aodong Pharmaceutical Group Co., Ltd.
000623
CN¥16.40
7D
-1.0%
1Y
12.3%
Viva Biotech Holdings
Market Cap: HK$3.5b
An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.
1873
HK$1.66
7D
4.4%
1Y
144.1%
NGeneBio
Market Cap: ₩39.3b
Develops in vitro diagnostics companion diagnostics products and bioinformatics software.
A354200
₩1,985.00
7D
-9.6%
1Y
-41.2%
Jinling Pharmaceutical
Market Cap: CN¥4.2b
Manufactures and sells pharmaceutical products and medical devices in China.
000919
CN¥6.67
7D
1.2%
1Y
-4.3%
Nectar Lifesciences
Market Cap: ₹5.4b
Manufactures and sells pharmaceutical products in India and internationally.
NECLIFE
₹23.90
7D
0.9%
1Y
-28.3%
Source Natural Foods and Herbal Supplements
Market Cap: ₹1.1b
Manufactures and sells ayurveda, health and dietary supplements, and food products in India.
531398
₹166.90
7D
1.2%
1Y
94.8%
Telix Pharmaceuticals
Market Cap: AU$8.5b
A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States.
TLX
AU$25.25
7D
0.4%
1Y
62.0%
China Regenerative Medicine International
Market Cap: HK$103.4m
An investment holding company, engages in the provision of healthcare products and services in Hong Kong and the People’s Republic of China.
8158
HK$0.34
7D
-15.0%
1Y
107.3%
Neurizon Therapeutics
Market Cap: AU$66.5m
A clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases in Switzerland, Australia, the United States, and internationally.
NUZ
AU$0.14
7D
-10.0%
1Y
-25.0%
Yuhan
Market Cap: ₩7.9t
Manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally.
A000100
₩105,000.00
7D
-1.9%
1Y
46.2%
AlzeCure Pharma
Market Cap: SEK 219.9m
Operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.
ALZCUR
SEK 2.46
7D
-1.6%
1Y
8.4%
Toleranzia
Market Cap: SEK 129.5m
A biotechnology company, develops and commercializes drugs for the treatment of autoimmune orphan diseases.
TOL
SEK 0.48
7D
3.5%
1Y
-20.1%
LungLife AI
Market Cap: UK£1.1m
A diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People’s Republic of China.
LLAI
UK£0.037
7D
7.1%
1Y
-79.7%
Lipidor
Market Cap: SEK 202.9m
A pharmaceutical development company, engages in the development of drugs for the treatment of psoriasis, acne vulgaris, bacterial skin infections, and atopic dermatitis.
LIPI
SEK 0.23
7D
-23.7%
1Y
12.2%
Hemogenyx Pharmaceuticals
Market Cap: UK£7.7m
A clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of treatments for blood cancer.
HEMO
UK£1.77
7D
-0.8%
1Y
-70.9%
Dermapharm Holding
Market Cap: €1.9b
Manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.
DMP
€35.20
7D
-0.8%
1Y
-6.0%
Ulisse Biomed
Market Cap: €20.3m
A healthcare biotech company, develops, produces, and markets vitro diagnostic medical devices in Italy.
UBM
€0.82
7D
-1.0%
1Y
-28.2%
Enorama Pharma
Market Cap: SEK 178.4m
A pharmaceutical company, develops, manufactures, and sells medicated chewing gum containing proven generic substances in Sweden.
ERMA
SEK 2.88
7D
-2.4%
1Y
19.5%
Organogenesis Holdings
Market Cap: US$381.8m
A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.
ORGO
US$2.97
7D
-2.0%
1Y
10.4%